Patents by Inventor Pierre Weiss
Pierre Weiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11937908Abstract: A method of performing magnetic resonance imaging of a body includes a) immerging the body in a static and substantially uniform magnetic field; b) exciting nuclear spins inside the body using at least one radio-frequency pulse; c) applying to the body a time-varying magnetic field gradient defining at least one trajectory (ST) in k-space and simultaneously acquiring samples of a magnetic resonance signal so as to perform a pseudo-random sampling (KS) of the k-space; and d) applying a sparsity-promoting nonlinear reconstruction algorithm for reconstructing a magnetic resonance image of the body; wherein, at least in a low-spatial frequency region of the k-space, the distance between any two adjacent points belonging to a same trajectory is lower than 1/FOV, FOV being the size of a field of view of the reconstructed image. A magnetic resonance imaging apparatus for carrying out such a method is also provided.Type: GrantFiled: September 6, 2018Date of Patent: March 26, 2024Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES PARIS, FRANCE, UNIVERSITÉ PARIS-SACLAY, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Nicolas Chauffert, Philippe Ciuciu, Jonas Kahn, Carole Lazarus, Alexandre Vignaud, Pierre Weiss
-
Publication number: 20230201422Abstract: The present invention relates to the use of a formulation comprising a phosphocalcic cement and a physical and/or ovalent hydrogel of polysaccharides for 3D printing, more particularly for bone regeneration and/or bone repair. The present invention also relates to a kit for 3D printing of bone implants comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides as well as to a method to prepare a formulation for 3D printing comprising a step of mixing a phosphocalcic cement and a physical and/or covalent liquid hydrogel precursor of polysaccharides.Type: ApplicationFiled: April 16, 2021Publication date: June 29, 2023Inventors: Marie-Michèle GERMAINI, Pierre Weiss, Pierre CORRE, Hélène GAUTIER
-
Patent number: 11220957Abstract: An exhaust gas turbocharger includes a turbine casing (4) within which a turbine wheel (10) is rotatably arranged relative to an axis of rotation (1). A guide vane ring (22) is non-rotatably arranged which comprises variable guide vanes (44) which are arranged upstream of the turbine wheel (10) with respect to an exhaust gas flow. The guide vane ring (22) is centered by means of a matched pair of two contact surfaces (24, 26) pressed against each other with respect to the turbine casing (4), of which at least the one contact surface (24 or 26, respectively) is formed conically.Type: GrantFiled: June 5, 2019Date of Patent: January 11, 2022Assignee: IHI Charging Systems International GmbHInventor: Marc-Pierre Weiß
-
Patent number: 11215068Abstract: An adjustable guide apparatus for a turbine, comprising a bearing ring with a plurality of guide vanes, wherein the guide vanes are rotatably mounted on the bearing ring with the aid of guide vane shafts, wherein in order to position the guide vane, the guide vane shaft is allocated an adjusting lever which engages in a rotatable rotating ring of the adjustable guide apparatus, and wherein, in order to be held in an exhaust gas guiding section of the turbine, the adjustable guide apparatus has a support ring, and wherein the support ring serves to mount the rotating ring. The rotating ring is radially and/or axially guided with the aid of at least one guiding element, wherein the guiding element is received on the support ring. Furthermore, the invention relates to a turbine with an adjustable guide apparatus and to an exhaust turbocharger.Type: GrantFiled: February 3, 2020Date of Patent: January 4, 2022Assignee: IHI CHARGING SYSTEMS INTERNATIONAL GMBHInventors: Max Model, Marc-Pierre Weiss, Vladimir Petrov
-
Patent number: 11156121Abstract: An adjustable guide apparatus for a turbine, comprising a bearing ring with a plurality of guide vanes, wherein the guide vanes are rotatably mounted on the bearing ring with the aid of guide vane shafts, wherein, in order to position the guide vane, the guide vane shaft is allocated an adjusting lever which is designed to be able to engage in a rotatable rotating ring of the adjustable guide apparatus, and wherein, in order to be held in an exhaust gas guiding section of the turbine, the adjustable guide apparatus has a support ring, and wherein the support ring serves to mount the rotating ring. In accordance with the invention the rotating ring is formed to be free of contact with the support ring. Furthermore, the invention relates to a turbine and to an exhaust turbocharger.Type: GrantFiled: February 4, 2020Date of Patent: October 26, 2021Assignee: IHI CHARGING SYSTEMS INTERNATIONAL GMBHInventors: Max Model, Marc-Pierre Weiss, Vladimir Petrov
-
Publication number: 20210054783Abstract: An exhaust gas turbocharger includes a turbine casing (4) within which a turbine wheel (10) is rotatably arranged relative to an axis of rotation (1). A guide vane ring (22) is non-rotatably arranged which comprises variable guide vanes (44) which are arranged upstream of the turbine wheel (10) with respect to an exhaust gas flow. The guide vane ring (22) is centered by means of a matched pair of two contact surfaces (24, 26) pressed against each other with respect to the turbine casing (4), of which at least the one contact surface (24 or 26, respectively) is formed conically.Type: ApplicationFiled: June 5, 2019Publication date: February 25, 2021Applicant: IHI Charging Systems International GmbHInventor: Marc-Pierre Weiß
-
Patent number: 10874588Abstract: A reservoir for liquid medicament includes a first boundary portion and a second boundary portion forming at least one cavity to receive the medicament. The first boundary portion is flexible, while the second boundary portion is rigid. At least one of the first and second boundary portions is a transparent boundary portion covered by an opaque cover which is at least partially detachable from the transparent boundary portion.Type: GrantFiled: February 11, 2015Date of Patent: December 29, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Michael Schabbach, Daniel Auernhammer, Daniel Wagner, Bernd Kuhn, Isabel Klein, Pierre Weiss, Klaus Schepers, Horst Mischo
-
Publication number: 20200205692Abstract: A method of performing magnetic resonance imaging of a body includes a) immerging the body in a static and substantially uniform magnetic field; b) exciting nuclear spins inside the body using at least one radio-frequency pulse; c) applying to the body a time-varying magnetic field gradient defining at least one trajectory (ST) in k-space and simultaneously acquiring samples of a magnetic resonance signal so as to perform a pseudo-random sampling (KS) of the k-space; and d) applying a sparsity-promoting nonlinear reconstruction algorithm for reconstructing a magnetic resonance image of the body; wherein, at least in a low-spatial frequency region of the k-space, the distance between any two adjacent points belonging to a same trajectory is lower than 1/FOV, FOV being the size of a field of view of the reconstructed image. A magnetic resonance imaging apparatus for carrying out such a method is also provided.Type: ApplicationFiled: September 6, 2018Publication date: July 2, 2020Inventors: Nicolas CHAUFFERT, Philippe CIUCIU, Jonas KAHN, Carole LAZARUS, Alexandre VIGNAUD, Pierre WEISS
-
Publication number: 20200173304Abstract: An adjustable guide apparatus for a turbine, comprising a bearing ring with a plurality of guide vanes, wherein the guide vanes are rotatably mounted on the bearing ring with the aid of guide vane shafts, wherein, in order to position the guide vane, the guide vane shaft is allocated an adjusting lever which is designed to be able to engage in a rotatable rotating ring of the adjustable guide apparatus, and wherein, in order to be held in an exhaust gas guiding section of the turbine, the adjustable guide apparatus has a support ring, and wherein the support ring serves to mount the rotating ring. In accordance with the invention the rotating ring is formed to be free of contact with the support ring. Furthermore, the invention relates to a turbine and to an exhaust turbocharger.Type: ApplicationFiled: February 4, 2020Publication date: June 4, 2020Applicant: IHI CHARGING SYSTEMS INTERNATIONAL GMBHInventors: MAX MODEL, MARC-PIERRE WEISS, VLADIMIR PETROV
-
Publication number: 20200173303Abstract: An adjustable guide apparatus for a turbine, comprising a bearing ring with a plurality of guide vanes, wherein the guide vanes are rotatably mounted on the bearing ring with the aid of guide vane shafts, wherein in order to position the guide vane, the guide vane shaft is allocated an adjusting lever which engages in a rotatable rotating ring of the adjustable guide apparatus, and wherein, in order to be held in an exhaust gas guiding section of the turbine, the adjustable guide apparatus has a support ring, and wherein the support ring serves to mount the rotating ring. The rotating ring is radially and/or axially guided with the aid of at least one guiding element, wherein the guiding element is received on the support ring. Furthermore, the invention relates to a turbine with an adjustable guide apparatus and to an exhaust turbocharger.Type: ApplicationFiled: February 3, 2020Publication date: June 4, 2020Applicant: IHI CHARGING SYSTEMS INTERNATIONAL GMBHInventors: MAX MODEL, MARC-PIERRE WEISS, VLADIMIR PETROV
-
Patent number: 10632154Abstract: The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si-HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.Type: GrantFiled: November 10, 2016Date of Patent: April 28, 2020Assignees: Ecole Nationale Veterinaire, Chu Nantes, Universite de Nantes, Institute National de la Sante et de la Recherche MedicaleInventors: Jean-Marie Bach, Mathilde Mosser, Apolline Salama, Anne Moure, Xavier Leveque, Pierre Weiss, Jérôme Guicheux, Cécile Boyer, David Riochet
-
Patent number: 10632203Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.Type: GrantFiled: April 10, 2018Date of Patent: April 28, 2020Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITE DE NANTESInventors: Pierre Weiss, Eva Mathieu, Jerome Guicheux, Patricia Lemarchand
-
Publication number: 20180318358Abstract: The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si—HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.Type: ApplicationFiled: November 10, 2016Publication date: November 8, 2018Inventors: Jean-Marie BACH, Mathilde MOSSER, Apolline SALAMA, Anne MOURE, Xavier LEVEQUE, Pierre WEISS, Jérôme GUICHEUX, Cécile BOYER, David RIOCHET
-
Publication number: 20180221493Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.Type: ApplicationFiled: April 10, 2018Publication date: August 9, 2018Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Nantes, CHU NantesInventors: Pierre Weiss, Eva Mathieu, Jerome Guicheux, Patricia Lemarchand
-
Patent number: 9968681Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.Type: GrantFiled: June 4, 2012Date of Patent: May 15, 2018Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Nantes, CHU NantesInventors: Pierre Weiss, Eva Mathieu, Jérôme Guicheux, Patricia Lemarchand
-
Patent number: 9642939Abstract: The present invention is directed to a novel cement powder comprising an organic component consisting of one or more biocompatible and bioresorbable polymers and an inorganic component consisting of one or more calcium phosphate compounds. The invention also relates to the apatitic CPC resulting from the mixing of said cement powder with a liquid phase and setting.Type: GrantFiled: August 23, 2007Date of Patent: May 9, 2017Assignees: GRAFTYS, UNIVERSITE DE NANTESInventors: Ibrahim Khairoun, Pierre Weiss, Jean-Michel Bouler
-
Publication number: 20170007500Abstract: A reservoir for liquid medicament includes a first boundary portion and a second boundary portion forming at least one cavity to receive the medicament. The first boundary portion is flexible, while the second boundary portion is rigid. At least one of the first and second boundary portions is a transparent boundary portion covered by an opaque cover which is at least partially detachable from the transparent boundary portion.Type: ApplicationFiled: February 11, 2015Publication date: January 12, 2017Inventors: Michael Schabbach, Daniel Auernhammer, Daniel Wagner, Bernd Kuhn, Isabel Klein, Pierre Weiss, Klaus Schepers, Horst Mischo
-
Publication number: 20170007767Abstract: The present invention relates to a reservoir (10; 30; 40) for a liquid medicament (11), comprising: a first boundary portion (16; 36; 46) and a second boundary portion (18; 38; 48) forming a cavity (12; 32; 42) to receive the medicament, wherein the first boundary portion is sub-stantially opaque and flexible, and wherein the second boundary portion is substantially transparent and rigid.Type: ApplicationFiled: February 11, 2015Publication date: January 12, 2017Inventors: Michael Schabbach, Daniel Wagner, Daniel Auernhammer, Pierre Weiss, Klaus Schepers, Horst Mischo
-
Patent number: 9285360Abstract: The invention concerns: —a silylated biomolecule having the following formula (I): —the process for the preparation of a silylated biomolecule of formula (I), —the use of a silylated biomolecule of formula (I) to functionalize the surface of a support, —a process for the preparation of a hydrogel by use of a silylated biomolecule of formula (I), the hydrogel obtainable by said process, —said hydrogel as a biological tissue substitute, —a composition comprising said hydrogel in a pharmaceutically acceptable vehicle, —said composition for the release of active principle.Type: GrantFiled: January 25, 2011Date of Patent: March 15, 2016Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Nantes, CHU Nantes, Institut Francais de Recherche pour l'Exploitation De la Mer—IFREMERInventors: Pierre Weiss, Jerome Guicheux, Gildas Rethore, Emile Rederstorff, Samia Laib
-
Publication number: 20140161775Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.Type: ApplicationFiled: June 4, 2012Publication date: June 12, 2014Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CHU NANTES, UNIVERSITE DE NANTESInventors: Pierre Weiss, Eva Mathieu, Jérôme Guicheux, Patricia Lemarchand